Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2005
06/01/2005CN1621529A Micro-nucleic acid releasing agent
06/01/2005CN1621522A Cholesterin dehydrogenase stabilization method, composition containing cholesterin dehydrogenase and cholesterin detection reagent
06/01/2005CN1621341A Process for preparing water-soluble carbon nano tube coated with self-assembled material
06/01/2005CN1204398C Biosensor
06/01/2005CN1204267C Intracellular nucleic acid testing method and device
06/01/2005CN1204266C Means and method for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy
06/01/2005CN1204265C Method of concentrating and recovering a viral enzyme activity from biological samples
06/01/2005CN1204264C Method and device for identifying pathogenic influence of concurrent bacteria infection against poultry influenza virus infection
06/01/2005CN1204263C Cell 'pungent edge inhibition effect' and contact inhibition observation dishware and its application
06/01/2005CN1204256C Technology for detecting foot and mouth disease virus antibody of sick livestock using recombination foot and mouth disease vaccine gene expressing protein
06/01/2005CN1204248C Process for preparing target ribonuclease for curing hepatitis B virus infection
05/2005
05/31/2005US6900367 Transgenic Drosophila melanogaster expressing a β42 in the eye
05/31/2005US6900304 Emission ratiometric indicators of phosphorylation
05/31/2005US6900300 Quadruplex DNA and duplex probe systems
05/31/2005US6900297 A compound which hybridizes with a nucleic acid includes multiple inked nucleosides (inlcudes a pentofuranosyl sugar portion and a base portion), and at least one sugar o-is terminated with R-N(R1a R1b) substitutent
05/31/2005US6900288 Comprises membrane glycoproteins for diagnosis, prevention and treatment of nervous system and cell proliferative disorders
05/31/2005US6900238 HIV protease inhibitors
05/31/2005US6900053 Antisense modulation of fibroblast growth factor receptor 2 expression
05/31/2005US6900048 Biopolymer arrays and their fabrication
05/31/2005US6900043 Phosphatases which activate map kinase pathways
05/31/2005US6900041 Adding compound suspected of effecting glycogen synthase kinase 3 beta (GSK-3 beta ) to cells; adding an inflammatory molecule; measuring determinant of GSK- 3 beta
05/31/2005US6900038 eNOS mutations useful for gene therapy and therapeutic screening
05/31/2005US6900032 Human PTTG polypeptide and method for producing it
05/31/2005US6900030 Device for monitoring cells
05/31/2005US6900028 Reflective disc assay devices, systems and methods
05/31/2005US6900022 Prostate cancer-specific marker
05/31/2005US6900020 Identifying prorenin modulators for treatment of cardiovascular and organ hypertrophy; enzyme inhibitors; mimetics
05/31/2005US6900018 Method of screening for a biological response using linear and circular expression elements
05/31/2005US6900016 Polymorphisms in known genes associated with inflammatory autoimmune disease, methods of detection and uses thereof
05/31/2005US6900015 Measurement of protective genes in allograft rejection
05/31/2005US6900013 Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
05/31/2005US6900010 Taking a culture of recombinant cells comprises a reporter sequence; contacting cell culture with a sample containing HIV; adding a tester agent to the cell culture; and detecting change in a level of expression of reporter gene in culture
05/31/2005US6899881 H. PYLORI FlbA POLYPEPTIDES, IMMUNOGENIC AND VACCINATING COMPOSITIONS COMPRISING H. PYLORI FlbA POLYPEPTIDES, AND COMPOSITIONS FOR DETECTION OF AN INFECTION COMPRISING H. PYLORI FlbA POLYPEPTIDES
05/31/2005US6899864 Kit and method for targeting of a diagnostic or therapeutic agent to target site in mammal having a pathological condition
05/31/2005US6899283 Liquid droplet ejecting method and a liquid droplet ejection apparatus
05/31/2005US6899137 Microfabricated elastomeric valve and pump systems
05/26/2005WO2005048165A2 Method to predict upper aerodigestive tract cancer
05/26/2005WO2005047904A2 High-density amine-functionalized surface
05/26/2005WO2005047901A2 Compositions and methods for detection and isolation phosphorylated molecules
05/26/2005WO2005047898A2 Methods and compositions for identifying therapeutic compounds
05/26/2005WO2005047897A1 Method of diagnosing alzheimer’s disease
05/26/2005WO2005047894A1 Circuit for electrochemical sensor strip
05/26/2005WO2005047864A2 Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules
05/26/2005WO2005047855A2 Method of preparing nucleic acids for detection
05/26/2005WO2005047547A1 Concatameric ligation products: compositions, methods and kits for same
05/26/2005WO2005047546A2 Diagnostic and prognostic methods and compositions for seizure- and plasticity-related disorders
05/26/2005WO2005047545A2 Microarray controls
05/26/2005WO2005047544A1 Risk assessment for adverse drug reactions
05/26/2005WO2005047543A2 Ligation assay
05/26/2005WO2005047542A1 Treatments for inhibiting development and progression of nevi and melanoma having braf mutations
05/26/2005WO2005047541A1 Oscillating temperature capillary electrophoresis and uses therefor
05/26/2005WO2005047540A1 Method of detecting predisposition to high altitude pulmonary edema
05/26/2005WO2005047539A1 Molecular marker
05/26/2005WO2005047538A2 Ligands of the mycobacterial repressor ethr, selection methods, and applications
05/26/2005WO2005047537A2 Diagnosis of distal hereditary motor neuropathy type ii by detection of hsp22 gene polymorphisms
05/26/2005WO2005047536A2 Detection of genomic amplification and deletion in cancer
05/26/2005WO2005047535A1 Method for amplification of rna sequences
05/26/2005WO2005047534A2 Methods and compositions for the response prediction of malig-nant neoplasia to treatment
05/26/2005WO2005047533A1 Method of detecting mutations associated with thrombosis
05/26/2005WO2005047532A1 Improved method of performing genetic analyses on reproductive tract cell samples
05/26/2005WO2005047531A1 Assay for pkc-beta activation of phosphorylation of myosin heavy chain polypeptide
05/26/2005WO2005047530A2 Method for assaying compounds that modulate the activity of protein tyrosine phosphatase receptor zeta (ptprzeta)
05/26/2005WO2005047529A1 Methods, compositions, and automated systems for separating rare cells from fluid samples
05/26/2005WO2005047528A1 Electrode for electrochemical sensors
05/26/2005WO2005047527A1 Electrochemical sensor strip
05/26/2005WO2005047526A2 Method for identifying inhibitors using a homology model of polo-like kinase 1
05/26/2005WO2005047525A1 Methods of validating target for modulating insulin action, screening for modulators of insulin action and therapeutic uses thereof
05/26/2005WO2005047523A2 Short cycle methods for sequencing polynucleotides
05/26/2005WO2005047522A2 Oligonucleotides and methods for detection of west nile virus
05/26/2005WO2005047521A2 Methods of preparing nucleic acid for detection
05/26/2005WO2005047519A2 Lsamp and nore 1 down-regulation in clear cell renal cell carcinomas
05/26/2005WO2005047509A2 The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses
05/26/2005WO2005047481A2 Novel sequences encoding hapatitis c virus glycoproteins
05/26/2005WO2005047477A2 Interspersed repetitive element rnas as substrates, inhibitors and delivery vehicles for rnai
05/26/2005WO2005047476A2 Inhibition of retroviral replication through modulation of the host cell ubiquitylation
05/26/2005WO2005047474A2 Nucleic acid detection method having increased sensitivity
05/26/2005WO2005047472A2 Increasing seed threonine content through alteration of threonine aldolase activity
05/26/2005WO2005047471A2 Improved fret efficiency methods
05/26/2005WO2005047470A2 Intercalator fret donors or acceptors
05/26/2005WO2005047468A2 Improved methods for detecting and measuring specific nucleic acid sequences
05/26/2005WO2005047463A2 Hcv replicons containing ns5b from genotype 2b
05/26/2005WO2005047462A2 Universal control for nucleic acid amplification
05/26/2005WO2005047461A2 Polypeptide display libraries and methods of making and using thereof
05/26/2005WO2005047459A2 Sars nucleic acids, proteins, antibodies, and uses thereof
05/26/2005WO2005047454A1 Plate containing amino acid medium and screening method with the use of plate containing amino acid medium
05/26/2005WO2005047451A2 Isolation of nucleic acid from mouth epithelial cells
05/26/2005WO2005047320A2 Equine p-selection glycoprotein ligand-1 and uses thereof
05/26/2005WO2005047308A2 Peptide-based diagnostic reagents for sars
05/26/2005WO2005047306A2 A prion-like form of cpeb and related compositions and methods
05/26/2005WO2005047301A1 Improvements in or relating to polynucleotide arrays
05/26/2005WO2005047245A2 Fluorescence assays with improved blocking groups
05/26/2005WO2005046731A1 Interference with c-maf function in multiple myeloma
05/26/2005WO2005046718A1 Diagnosis and hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in pancreas cells (12.1)
05/26/2005WO2005046703A1 Use of strain of bacillus and byproducts thereof for inhibiting formation of blood vessels
05/26/2005WO2005046617A2 Compositions and methods for reducing microbial induced apoptosis
05/26/2005WO2005046616A2 Viral propagation system and uses thereof
05/26/2005WO2005046606A2 Compositions and methods for diagnosing and treating chronic lymphocytic leukemia
05/26/2005WO2005046585A2 Vps35-based assays and methods for treating alzheimer’s disease
05/26/2005WO2005046564A2 Diagnosis and treatment of liver fibrosis
05/26/2005WO2005046459A2 Primers, methods and kits for detecting killer-cell immunoglobulin-like receptor alleles
1 ... 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 ... 3003